Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants
| dc.contributor.author | Rayner, B L | |
| dc.date.accessioned | 2016-04-23T12:42:43Z | |
| dc.date.available | 2016-04-23T12:42:43Z | |
| dc.date.issued | 2012 | |
| dc.date.updated | 2016-04-21T08:39:01Z | |
| dc.description.abstract | Atrial fibrillation (AF) is a common clinical condition that is associated with increased morbidity and mortality that mainly relates to an embolic stroke. Dominant risk factors for AF are advanced age and hypertension in the absence of mitral valve disease.1 In turn, hypertension and ageing are determinants of the congestive heart failure, hypertension, age, diabetes mellitus, prior stroke or transient ischaemic attack or thromboembolism (CHADS2) criteria for assessing the indication for anticoagulation. In addition, they are important risk factors for chronic kidney disease (CKD). In itself, CKD is an independent risk factor for AF and a higher risk of stroke.2 It is highly likely that a practitioner will encounter older patients with AF and concomitant hypertension and CKD that require anticoagulation therapy. Thus, it is essential for the practitioner to understand the risks and benefits of anticoagulation in older patients with AF, hypertension and CKD. | en_ZA |
| dc.identifier | http://dx.doi.org/10.1080/20786204.2012.10874263 | |
| dc.identifier.apacitation | Rayner, B. L. (2012). Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants. <i>South African Family Practice</i>, http://hdl.handle.net/11427/19155 | en_ZA |
| dc.identifier.chicagocitation | Rayner, B L "Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants." <i>South African Family Practice</i> (2012) http://hdl.handle.net/11427/19155 | en_ZA |
| dc.identifier.citation | Rayner, B. (2012). Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants. South African Family Practice, 54(5), 418-419. | en_ZA |
| dc.identifier.issn | 2078-6190 | en_ZA |
| dc.identifier.ris | TY - Journal Article AU - Rayner, B L AB - Atrial fibrillation (AF) is a common clinical condition that is associated with increased morbidity and mortality that mainly relates to an embolic stroke. Dominant risk factors for AF are advanced age and hypertension in the absence of mitral valve disease.1 In turn, hypertension and ageing are determinants of the congestive heart failure, hypertension, age, diabetes mellitus, prior stroke or transient ischaemic attack or thromboembolism (CHADS2) criteria for assessing the indication for anticoagulation. In addition, they are important risk factors for chronic kidney disease (CKD). In itself, CKD is an independent risk factor for AF and a higher risk of stroke.2 It is highly likely that a practitioner will encounter older patients with AF and concomitant hypertension and CKD that require anticoagulation therapy. Thus, it is essential for the practitioner to understand the risks and benefits of anticoagulation in older patients with AF, hypertension and CKD. DA - 2012 DB - OpenUCT DP - University of Cape Town J1 - South African Family Practice LK - https://open.uct.ac.za PB - University of Cape Town PY - 2012 SM - 2078-6190 T1 - Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants TI - Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants UR - http://hdl.handle.net/11427/19155 ER - | en_ZA |
| dc.identifier.uri | http://hdl.handle.net/11427/19155 | |
| dc.identifier.uri | http://www.tandfonline.com/doi/pdf/10.1080/20786204.2012.10874263 | |
| dc.identifier.vancouvercitation | Rayner BL. Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants. South African Family Practice. 2012; http://hdl.handle.net/11427/19155. | en_ZA |
| dc.language | eng | en_ZA |
| dc.publisher | South African Academy of Family Physicians | en_ZA |
| dc.publisher.department | Division of Nephrology and Hypertension | en_ZA |
| dc.publisher.faculty | Faculty of Health Sciences | en_ZA |
| dc.publisher.institution | University of Cape Town | |
| dc.rights | Creative Commons Attribution-Noncommercial-No Derivative Works 2.5 South Africa License | * |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/2.5/za/ | en_ZA |
| dc.source | South African Family Practice | en_ZA |
| dc.source.uri | http://www.safpj.co.za/index.php/safpj | |
| dc.subject.other | hypertension | |
| dc.subject.other | chronic kidney disease | |
| dc.subject.other | atrial fibrillation | |
| dc.subject.other | anticoagulants | |
| dc.title | Hypertension, chronic kidney disease, atrial fibrillation and the newer anticoagulants | en_ZA |
| dc.type | Journal Article | en_ZA |
| uct.type.filetype | Text | |
| uct.type.filetype | Image | |
| uct.type.publication | Research | en_ZA |
| uct.type.resource | Article | en_ZA |